Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

3.06
Delayed Data
As of Jun 28
 +0.0635 / +2.12%
Today’s Change
1.93
Today|||52-Week Range
7.85
-3.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.0K------
 
 
 
Operating ExpensesGross Income-1.0K0.000.000.00
 
 
General Expenses471.1K305.4K344.7K337.3K
 
 
 
 
 
Research And Development123.6K35.6K53.0K23.7K
 
 
 
 
 
Total Operating Expenses472.1K305.4K344.7K337.3K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-472.1K-305.4K-344.7K-337.3K
 
 
 
 
 
Extraordinary Charge0.000.00-847.3K0.00
 
 
Other Expenses-11.1K-1.0K-12.0K-688.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-483.2K-291.1K-1.2M-1.0M
 
 
 
 
 
Net Income-483.2K-291.1K-1.2M-1.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M2.7M2.7M3.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M2.7M2.7M3.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.10---$0.31
 
 
 
 
EPS Diluted-$0.20-$0.10-$0.40-$0.31